Literature DB >> 18939621

Control of avian mycoplasma infections in commercial poultry.

S H Kleven1.   

Abstract

Control of pathogenic avian mycoplasmas can consist of one of three general approaches: Maintaining flocks free of infection, medication, or vaccination. Maintaining flocks free of pathogenic mycoplasmas consists of maintaining replacements from mycoplasma-free sources in a single-age, all-in all-out management system. Good biosecurity and an effective monitoring system are necessary aspects of this program. Medication can be very useful in preventing clinical signs and lesions, as well as economic losses, but cannot be used to eliminate infection from a flock and is therefore not a satisfactory long-term solution. Vaccination against Mycoplasma gallisepticum (MG) or M. synoviae (MS) can be a useful long-term solution in situations where maintaining flocks free of infection is not feasible, especially on multi-age commercial egg production sites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18939621     DOI: 10.1637/8323-041808-Review.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  28 in total

1.  Occurrence of concurrent infectious diseases in broiler chickens is a threat to commercial poultry farms in Central Ethiopia.

Authors:  Mersha Chanie; Tamiru Negash; Samuel Bekele Tilahun
Journal:  Trop Anim Health Prod       Date:  2009-02-21       Impact factor: 1.559

2.  Development of Molecular Methods for Rapid Differentiation of Mycoplasma gallisepticum Vaccine Strains from Field Isolates.

Authors:  Kinga M Sulyok; Zsuzsa Kreizinger; Katinka Bekő; Barbara Forró; Szilvia Marton; Krisztián Bányai; Salvatore Catania; Christine Ellis; Janet Bradbury; Olusola M Olaogun; Áron B Kovács; Tibor Cserép; Miklós Gyuranecz
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

3.  Detection and differentiation of avian mycoplasmas by surface-enhanced Raman spectroscopy based on a silver nanorod array.

Authors:  Suzanne L Hennigan; Jeremy D Driskell; Naola Ferguson-Noel; Richard A Dluhy; Yiping Zhao; Ralph A Tripp; Duncan C Krause
Journal:  Appl Environ Microbiol       Date:  2011-12-30       Impact factor: 4.792

4.  Differential house finch leukocyte profiles during experimental infection with Mycoplasma gallisepticum isolates of varying virulence.

Authors:  Natalie M Bale; Ariel E Leon; Dana M Hawley
Journal:  Avian Pathol       Date:  2020-05-18       Impact factor: 3.378

5.  Immunologic Pathways in Protective versus Maladaptive Host Responses to Attenuated and Pathogenic Strains of Mycoplasma gallisepticum.

Authors:  Jessica Beaudet; Edan R Tulman; Katherine Pflaum; Jessica A Canter; Lawrence K Silbart; Steven J Geary
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

6.  Evidence for Multidrug Resistance in Nonpathogenic Mycoplasma Species Isolated from South African Poultry.

Authors:  Amanda Beylefeld; Pamela Wambulawaye; Dauda Garba Bwala; Johannes Jacobus Gouws; Obed Mooki Lukhele; Daniel Barend Rudolph Wandrag; Celia Abolnik
Journal:  Appl Environ Microbiol       Date:  2018-10-17       Impact factor: 4.792

7.  Differential Response of the Chicken Trachea to Chronic Infection with Virulent Mycoplasma gallisepticum Strain Ap3AS and Vaxsafe MG (Strain ts-304): a Transcriptional Profile.

Authors:  Glenn F Browning; Nadeeka K Wawegama; Sathya N Kulappu Arachchige; Neil D Young; Pollob K Shil; Alistair R Legione; Anna Kanci Condello
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

8.  Core Genome Multilocus Sequence Typing: a Standardized Approach for Molecular Typing of Mycoplasma gallisepticum.

Authors:  Mostafa Ghanem; Leyi Wang; Yan Zhang; Scott Edwards; Amanda Lu; David Ley; Mohamed El-Gazzar
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

9.  Mycoplasma gallisepticum inactivated by targeting the hydrophobic domain of the membrane preserves surface lipoproteins and induces a strong immune response.

Authors:  Hazem Atalla; Inna Lysnyansky; Yossef Raviv; Shlomo Rottem
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

10.  Multi-epitope-Based Vaccine Designed by Targeting Cytoadherence Proteins of Mycoplasma gallisepticum.

Authors:  Susithra Priyadarshni Mugunthan; Mani Chandra Harish
Journal:  ACS Omega       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.